Using non-insulin medications for managing diabetes in hospitalized patients
Use of Non-Insulin Agents in Hospitalized Patients with Type 2 diabetes (T2D)
This study is looking at whether patients with type 2 diabetes can safely keep taking their non-insulin pills while in the hospital instead of switching to insulin, to see if it helps manage their blood sugar without causing extra problems or costs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10816996 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of continuing non-insulin oral medications for patients with type 2 diabetes who are hospitalized, compared to the traditional use of insulin. The study aims to determine if these medications can maintain blood sugar control without increasing complications or costs. By conducting a randomized controlled trial, the researchers will gather real-world data on the safety and efficacy of these treatments in a hospital setting. This approach seeks to improve diabetes management during hospital stays and inform future clinical practices.
Who could benefit from this research
Good fit: Ideal candidates for this research are hospitalized adults with type 2 diabetes who experience mild to moderate hyperglycemia.
Not a fit: Patients who are critically ill or require intensive insulin therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer and more effective diabetes management for hospitalized patients, reducing complications and improving recovery times.
How similar studies have performed: Previous studies have shown promising results with non-insulin therapies in hospital settings, indicating potential for success in this approach.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Fayfman, Maya — Emory University
- Study coordinator: Fayfman, Maya
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.